# Elaboration of a prognostic model associated with retinal hemorrhage in hemophagocytic lymphohistiocytosis

**Authors:** Huiwen Tian, Luping Wang, Yanli Hou, Zhaoyang Meng, Yu Wang, Hongyang Li

PMC · DOI: 10.1080/07853890.2026.2634471 · 2026-02-24

## TL;DR

This study develops a prognostic model showing that retinal hemorrhage is linked to worse outcomes in hemophagocytic lymphohistiocytosis patients.

## Contribution

A novel prognostic model for HLH patients based on retinal hemorrhage and related biomarkers is developed and validated.

## Key findings

- Retinal hemorrhage is associated with increased severity and poorer prognosis in HLH patients.
- Scattered hemorrhage correlates with higher sIL-2R and ferritin levels and shorter survival times.
- The prognostic model shows high sensitivity and specificity in predicting outcomes.

## Abstract

This retrospective case–control study focused on retinal hemorrhage associated with hemophagocytic lymphohistiocytosis (HLH), integrating various ocular examination parameters to investigate the survival and prognostic factors in HLH patients.

Of 1973 assessed patients, 104 were finally recruited and 1:1 matched into retinal hemorrhage and control groups, with the hemorrhage area further graded in the former. Demographic and hematological data were collected; central, inner, outer retinal thickness and choroidal vascularity index (CVI) were measured via optical coherence tomography (OCT). Cox proportional hazards regression models (CoxPH) were elaborated, followed by bootstrapping internal validation and external validation.

The hemorrhage group had significantly more intracranial lesions, lower hemoglobin, platelet count, and fibrinogen, and notably higher soluble interleukin-2 receptor (sIL-2R) and ferritin levels, along with significantly increased central inner retinal thickness,and reduced CVI. Ferritin and sIL-2R in the scattered hemorrhage group were significantly higher, and the survival time was significantly shorter than in the petechial hemorrhage group; scattered hemorrhage was predominant in moderate/high sIL-2R and ferritin subgroups. The CoxPH showed that retinal hemorrhage well predicted the survival and outcomes with a significantly higher hazard rate, and the model had high sensitivity, specificity, lower prediction error in external validation.

This study elaborated a prognostic model in HLH, revealing that retinal hemorrhage is a hazard factor associated with increased severity and poorer prognosis in HLH patients.

## Linked entities

- **Diseases:** hemophagocytic lymphohistiocytosis (MONDO:0015540)

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** Retinal hemorrhage (MESH:D012166), diabetic retinopathy (MESH:D003930), carcinoma (MESH:D009369), diabetes (MESH:D003920), retinal ganglion cell death (MESH:D012173), thrombocytopenia (MESH:D013921), rupture (MESH:D012421), ischemic (MESH:D002545), infections (MESH:D007239), ocular abnormalities (MESH:D005124), coagulation (MESH:D001778), hyperferritinemia (MESH:D000085583), intracranial lesion (MESH:D020765), rheumatologic diseases (MESH:D012216), orbital edema (MESH:D004487), chronic myelogenous leukemia (MESH:D015464), autoimmune hemolytic anemia (MESH:D000744), inflammation (MESH:D007249), retinal edema (MESH:D010211), anemia (MESH:D000740), syndrome (MESH:D013577), CHD (MESH:D003327), viral infection (MESH:D014777), vision damage (MESH:D014786), death (MESH:D003643), hypertension (MESH:D006973), cytopenias (MESH:D006402), Primary HLH (MESH:D051359), fever (MESH:D005334), malignant hematological diseases (MESH:D019337), ischemia (MESH:D007511), ocular diseases (MESH:D005128), acute leukemia (MESH:D015470), posterior segment abnormalities (MESH:C537538), Hypofibrinogenemia (MESH:D000347), fundus abnormalities (MESH:C535828), systemic diseases (MESH:D034721), bleeding (MESH:D006470), splenomegaly (MESH:D013163), organ failure (MESH:D009102), autoimmune (MESH:D001327), lymphoma (MESH:D008223), ILM (MESH:D015433), immune-mediated diseases (MESH:C567355), liver or brain injury (MESH:D017093), retinal damage (MESH:D012164), associated (MESH:D018886), vitreous hemorrhage (MESH:D014823), autoimmune uveitis (MESH:D014605), hepatic injury (MESH:D056486), aplastic anemia (MESH:D000741)
- **Chemicals:** triglyceride (MESH:D014280), -weight heparin (-), oxygen (MESH:D010100), cyclosporine A. (MESH:D016572), reactive oxygen species (MESH:D017382), glucose (MESH:D005947), lipids (MESH:D008055), iron (MESH:D007501)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943805/full.md

---
Source: https://tomesphere.com/paper/PMC12943805